|
|
|
Insider
Information: |
Gowen Maxine |
Relationship: |
Director |
City: |
W. Conshohocken |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
127,977 |
|
Indirect Shares
|
1,581,525 |
|
|
Direct
Value |
$70,671 |
|
|
Indirect Value
|
$169,317 |
|
|
Total
Shares |
1,709,502 |
|
|
Total
Value |
$239,988 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Santarus Inc |
SNTS |
former Director |
2004-04-06 |
20,000 |
2004-10-25 |
1,165,513 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-04-11 |
0 |
Premium* |
|
Trevena Inc |
TRVN |
President & CEO, Direc... |
2019-02-01 |
54,000 |
2019-02-01 |
416,012 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-06-08 |
24,133 |
2014-11-13 |
0 |
Premium* |
|
Aceragen, Inc |
ACGN |
|
2017-01-04 |
17,543 |
2023-08-10 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
12,301 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TRVN |
Trevena Inc |
President & CEOOfficer |
|
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
193,548 |
|
- |
|
SNTS |
Santarus Inc |
former Director |
|
2004-03-31 |
5 |
A |
$0.00 |
$0 |
I/I |
1,137,656 |
1,137,656 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2004-04-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,137,656 |
1,137,656 |
|
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
26,163 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
28,663 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2015-02-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
51,000 |
275,025 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-09-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
130,000 |
163,109 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-09-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
130,000 |
134,000 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2016-10-16 |
5 |
GA |
$0.00 |
$0 |
D/D |
10,542 |
1 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-10-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
145,025 |
18,084 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-10-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
145,025 |
144,000 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-10-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
14,084 |
139,109 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2016-10-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,084 |
4,000 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,000 |
4,000 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-01-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,000 |
150,000 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-01-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
114,403 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-01-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,500 |
145,109 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
64,403 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-03-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
195,109 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-03-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
216,500 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-03-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
4,403 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
403 |
4,000 |
0 |
- |
|
TRVN |
Trevena Inc |
President & CEO |
|
2017-05-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
403 |
195,512 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
15,000 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,438 |
4,438 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|